August 27, 2021
Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021
Media
August 26, 2021
Interim report April – June 2021
August 25, 2021
Spruce Biosciences Announces Pediatric Classic CAH Program Details During Virtual R&D Day
August 20, 2021
Oncopeptides publishes report for Q2 2021
August 18, 2021
Targovax ASA: second quarter and first half year 2021 results
August 17, 2021
Precirix enters into alliance with 3P Biopharmaceuticals for the manufacturing of single domain antibodies
August 12, 2021
VTX-801 Receives U.S. FDA Fast Track Designation for the Treatment of Wilson Disease
August 12, 2021
Fusion Pharmaceuticals And TRIUMF Announce Expanded R&D Collaboration For Actinium Supply Production
August 12, 2021
Aprea Therapeutics Reports Second Quarter 2021 Financial Results and Provides Update on Business Operations
August 12, 2021
Invitation to presentation of the Q2 2021 results
